Clinical Trial

A Pharmacokinetic Study of YN001 in Healthy Participants

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated December 18, 2025 (before its estimated February 4, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a Phase 1, single-center, open-label study designed to evaluate the pharmacokinetics (PK), safety, and immunogenicity following a single dose administration in healthy adult volunteers.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-17; most recent amendment 2025-12-11.
Status change: Not Yet Recruiting → Recruiting 2025-12-11
Trial Details
NCT Number NCT07190885
Lead Sponsor Beijing Inno Medicine Co., Ltd.
Conditions Healthy Volunteers
Enrollment 24 participants
Start Date 2025-11-18
Primary Completion 2026-02-04 (estimated)
Study Completion 2026-02-18 (estimated)
Updated on ClinicalTrials.gov 2025-12-18